- About Overview
- Honors and Awards
- Facts and Figures
- Support the School
- Contact Us
- Dean’s Office
- Patient Care
Wearable device monitors heart failure
By Katherine Krebs / Tue Feb 13, 2018
A new study published in Circulation: Heart Failure shows how bioengineers are teaming up with clinicians to improve patient outcomes.
“The concept behind the device in this paper originated with a bioengineering graduate student as a side project,” says co-author Shuvo Roy, PhD. “And it subsequently led to a strong collaboration between my lab and UCSF cardiologists Drs. Liviu Klein and Teresa De Marco, illustrating nicely how bioengineers and clinicians come naturally together at UCSF to tackle significant problems in medicine.”
The research demonstrates a wearable device in the form of a patch that senses and transmits information on a patient’s cardiac condition during exercise. This kind of remote monitoring of patients with heart failure could allow clinicians to make adjustments to treatment that take into account a patient’s changing condition, and could potentially reduce hospitalizations.
The initial idea came from Mozziyar Etemadi, MD, PhD, when he was a PhD bioengineering student in the Roy Lab. Co-author J. Alex Heller, MS, was also an engineer in the Roy Lab. Roy is a faculty member in the Department of Bioengineering and Therapeutic Sciences, a joint department of the UCSF Schools of Pharmacy and Medicine.
More about this research
About the School: The UCSF School of Pharmacy is a premier graduate-level academic organization dedicated to improving health through precise therapeutics. It succeeds through innovative research, by educating PharmD health professional and PhD science students, and by caring for the therapeutics needs of patients while exploring innovative new models of patient care. The School was founded in 1872 as the first pharmacy school in the American West. It is an integral part of UC San Francisco, a leading university dedicated to promoting health worldwide.